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This study describes the epidemiology of congenital amelia (absence of limb/s), using the largest series of cases
known to date. Data were gathered by 20 surveillance programs on congenital anomalies, all International
Clearinghouse for Birth Defects Surveillance and Researchmembers, from all continents but Africa, from 1968 to
2006, depending on the program. Reported clinical information on cases was thoroughly reviewed to identify
those strictly meeting the definition of amelia. Those with amniotic bands or limb-body wall complex were
excluded. The primary epidemiological analyses focused on isolated cases and those with multiple congenital
anomalies (MCA). A total of 326 amelia cases were ascertained among 23,110,591 live births, stillbirths and
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(for some programs) elective terminations of pregnancy for fetal anomalies. The overall total prevalence was
1.41 per 100,000 (95% confidence interval: 1.26–1.57). Only China Beijing and Mexico RYVEMCE had total
prevalences, which were significantly higher than this overall total prevalence. Some under-registration could
influence the total prevalence in some programs. Liveborn cases represented 54.6% of total. Amongmonomelic
cases (representing 65.2%of nonsyndromic amelia cases), both sides were equally involved, and the upper limbs
(53.9%) were slightly more frequently affected. One of the most interesting findings was a higher prevalence
of amelia among offspring of mothers younger than 20 years. Sixty-nine percent of the cases had MCA
or syndromes. The most frequent defects associated with amelia were other types of musculoskeletal
defects, intestinal, some renal and genital defects, oral clefts, defects of cardiac septa, and anencephaly.
 2011 Wiley Periodicals, Inc.
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INTRODUCTION
Amelia (from Greek: a ‘without, lack
of ’, plus μέλος ‘limb’) is a congenital
anomaly characterized by the complete
absence of one or more limbs. Accord-
ing to the classification suggested by
Frantz andO’Rahilly [1961] or Swanson
[1976], amelia constitutes a specific
group among the terminal transverse
reduction defects of the limbs.
Some Historical Aspects
Limb defects have always attracted gen-
eral attention, and the earliest known
written records are extremely ancient.
Their descriptions appear on clay tablets
found at Nineveh in the archives of the
Assyrian king Ashurbanipal (668–626
BC), referring to 62 different human
limb defects. Probably, the first patient of
known identity reported with amelia
was born in 1575 in Switzerland [Son-
deregger, 1927; Czeizel et al., 1994].
Since then, many other individual cases
have been reported.
Embryology of the Limbs
Human limb development initiates on
the 26th day after fertilization for the
upper limb and the 28th day for the
lower limb, and extends until day 56
[Sadler, 2009]. The appendicular skel-
eton develops from the lateral plate
mesoderm (split into paraxial and
somatic). Activation of the mesenchy-
mal cells of the lateral mesodermal plate
causes an outgrowth of the limb buds,
which become visible as outpocketings
from the ventrolateral body wall. Each
tissue (cartilage, bone, andmuscle) arises
through several mechanisms of differ-
entiation. In the limb bud,mesenchyme,
derived from the somatic layer of the
lateral plate mesoderm is the source of
the skeletal components that will form
the bones and connective tissues of the
limb. Mesenchyme derived from the
myotomes of the paraxial mesoderm
forms the muscular component [Moore
and Persaud, 2008]. The mesenchymal
core is covered by a layer of cuboidal
ectoderm which becomes thickened at
the distal rim of the limb bud to form the
apical ectodermal ridge (AER) on the
33rd day. This AER exerts an inductive
influence on the underlying mesen-
chyme [Summerbell, 1974]. Subjacent
to the AER, a vascular channel can be
found that is essential for the integrity of
the AER and for continued limb out-
growth. Mesenchyme adjacent to the
AER remains as a population of undif-
ferentiated, rapidly proliferating cells,
whereas cells located farther away from
the influence of the AER begin to
differentiate into cartilage and muscle.
According to the progress zone
model, a cell’s proximodistal identity is
determined by the length of time spent
in the distal limb region termed the
‘‘progress zone.’’ By 6 weeks, the hand
and foot plates are apparent. Develop-
ment of the feet is similar to that of the
hands, but starts approximately 2 days
later. As the limb bud grows, apoptosis in
the AER separates the ridge into five
parts and indentations become apparent
in the hand and foot plate. During the
7th and the 8th weeks of human
development the digits can be recog-
nized. The hand and foot plates become
separated from the proximal segment of
the limb by a circular constriction which
becomes the wrist and ankle. Later,
a second constriction at the level of the
elbow and knee divides the proximal
portion into two segments, so that the
main segments of the limb (proximal
stylopod, middle zeugopod, and distal
autopod) can be distinguished.
By the 6thweekof development the
first hyaline cartilage in the limbs can be
recognized. The skeleton of the limbs is
formed as a hyaline cartilage precursor
which ossifies by the end of the
embryonic period. Primary ossification
centers are present in all long bones of




The genetic processes that control
development of the limbs are compli-
cated and still not fully understood.
Some genes or gene families and molec-
ular genetic factors are known to be
involved in growth and differentiation
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of the developing limb [Barham and
Clarke, 2008], a process which is
spatially and temporally coordinated.
The products of those genes act as signals
to turn on other genetic pathways. Some
influence the initiation and patterning of
both the forelimb and the hindlimb, but
others are differentially expressed in the
developing forelimb and hindlimb. In
Table I, the main genes or gene families
involved in limb development are sum-
marized, and other details are provided
by Bermejo-Sa´nchez et al. [in press] in
this issue of the journal. Apart from the
action of these genetic factors, retinoic
acid (RA) levels must be carefully
controlled during limb bud develop-
ment since both high and low levels have
been associated with developmental
abnormalities. RA up-regulates the
Hox genes in the limb fields. It also
stimulates Sonic Hedgehog (SHH) up-
regulation, influences the creation of the
zone of polarizing activity (ZPA), con-
trols the condensation and differentia-
tion of chondroblasts and coordinates
chondrocyte maturation, osteoblast dif-
ferentiation, and bone formation.
Regarding the genetic aspects of
amelia, it usually occurs as a sporadic
event. Brent and Holmes [1988] noted
the more restricted etiologies for amelia
compared with the broader categories
of limb reduction defects. Amelia is not
generally considered to be of genetic
origin [Lenz, 1980]. In the study of
Froster-Iskenius and Baird [1990], no
evidence for familial recurrence was
observed. Although it may occur with
additional congenital anomalies, amelia
is an infrequent feature in genetic
syndromes. For example, if one intro-
duces ‘‘amelia’’ (affecting upper or lower
limbs) as a search criterion in the
Winter–Baraitser Dysmorphology Da-
tabase [Winter and Baraitser, 2010] and
the OMIM (Online Mendelian Inheri-
tance in Man) database [OMIM, 2011]
combined, the result is a list of only 31
syndromes meeting the search criterion
(Table II). Some of these are known
to be caused by mutations in specific
genes, such as WNT3 in Tetra-amelia
(OMIM 273395), or IRF6 in popliteal
pterygium syndrome. Table II also
includes the chromosome location and
responsible gene for those syndromes
where these are known.
Pathogenesis
It has been established that there are at
least three mechanisms by which limb
deficiencies can occur: (a) failure of
formation of the limb anlage in the very
early stages of embryo development,
which can be the result of errors in the
genetic control of limb development,
or an insult during blastogenesis
[Froster-Iskenius and Baird, 1990;
Martı´nez-Frı´as et al., 1997a]; (b) intra-
uterine amputation from amniotic bands
[Tadmor et al., 1997]; and (c) disruption
of the developing arterial supply to the
limb [Hoyme et al., 1982; Weaver,
1998]. Regarding the first mechanism,
the processes that take place for the
formation of the limbs, and the genes
controlling or affecting those processes,
have been explained above in detail.
With respect to amniotic bands, there is
evidence that they can form a constric-
tion around the developing limb that
interferes with its growth, resulting in
degrees of damage from a minor con-
striction band around a limb that is
otherwise normal to complete transverse
amputation. Disruption of the develop-
ing arterial supply may cause severe
ischemia of the limb bud, producing
the anomaly alsowith variable degrees of
severity and associated lesions. Such
disruption of the arterial supply can
be the consequence of uterine artery
occlusion, or exposure to factors which
diminish the blood flow at the uterine/
placental unit, such as cocaine or other
vasoconstrictive agents, or those causing
vasculitis or infectious arteritis, or vag-
inal bleeding. Moreover, some abnor-
malities of the placental–fetal unit
(observed in cases of placental insuffi-
ciency, twin arterial–arterial or arterial–
venous anastomoses, amnion rupture,
or umbilical cord obstruction), or an
abnormal fetal unit (due to disruption of
newly formed vessels, or external com-
pression of blood vessels, embolic events,
premature ablation of transient vessels,
or aberrant regulation of vessel forma-
tion) could have an effect. In fact,
placental vascular anastomoses between
the placentas in twins, which are more
frequent inmonozygotic twinning, have
been related to amelia by altering the
arterial supply [Phelan et al., 1998].
Epidemiology
Data on the prevalence of amelia are
scarce, and most published articles on
this congenital defect are single case
reports or limited series. Moreover, in
some studies cases of amelia were not
analyzed separately from other trans-
verse limb reduction defects or from
phocomelia (which is characterized by
the absence of the intermediate seg-
ments of the limb with the distal seg-
ments being present, and is reviewed
in this issue of the journal [Bermejo-
Sa´nchez et al., in press]). As can be
observed from the few published studies
providing data on this condition
(Table III), amelia has a low prevalence
ranging from 0.95 per 100,000 births
[Ka¨lle´n et al., 1984] to 1.71 per 100,000
births [Castilla et al., 1995]. However,
the prevalence of amelia among still-
births (SB) (varying from 34.56 per
100,000 [Martı´nez-Frı´as et al., 1997a]
to 79.05 per 100,000 [Froster and Baird,
1993]) was reported to be at least
30.9 times higher than that among live
births (LB) (Table III). In the study of
Castilla et al. [1995], 34% (n¼ 50) of the
Regarding the genetic aspects of
amelia, it usually occurs as a
sporadic event. Brent and
Holmes noted the more
restricted etiologies for amelia
compared with the broader
categories of limb reduction
defects. Amelia is not generally
considered to be of genetic
origin. In the study of
Froster-Iskenius and Baird,
no evidence for familial
recurrence was observed.
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TABLE I. Summary of the Molecular Embryology of the Limbs
Genes or
gene families Function
Pitx1 This belongs to an expanding family of bicoid-related vertebrate homeobox genes. It encodes a
transcription factor that is expressed throughout the developing hindlimb, but not in forelimb buds.
Pitx1 is not essential for hindlimb development, and if it is knocked out, the hindlimb will develop, but
with a morphology similar to that of a forelimb
T-box genes This is a family of transcription factors. Tbx4 and Tbx5 are expressed in the forelimb and hindlimb,
respectively. The temporal expression patterns of Tbx5, Tbx4, and Pitx1 suggest they play an important
role in programming the identity of the developing limb. Ectopically expressed Tbx5 can induce
expression of the forelimbmarkerHoxd9 and repress the hindlimbmarkerHoxc9 [Rodrı´guez-Esteban et
al., 1999; Takeuchi et al., 1999]. If Tbx5 is knocked out or inactivated, complete failure of formation of
any elements of the forelimb occurs. Tbx5 interacts with Fgf and Wnt to initiate outgrowth of the limb
bud [Agarwal et al., 2003; Rallis et al., 2003]. Tbx5 and Tbx4 activate fibroblast growth factor-10 (Fgf10) in
the forelimb and hindlimb, respectively
Fgf family FGF10 signals the ectoderm to induce Fgf8, which is instrumental in the formation of the AER at the tip
of the developing limb bud. FGF10 promotes Fgf8 expression, and FGF8 promotes Fgf10 expression in a
positive feedback loop, regulated by theWnt signaling pathway [Agarwal et al., 2003]. If Fgf10 is knocked
out in mice, no limb develops [Min et al., 1998]. Fgf4 is expressed at the dorsal end of the limb bud AER.
Fgf4 and Fgf8 expression stimulates and maintains the rapid growth of the progress zone and prevents the
localmesenchymal cells fromdifferentiating into chondrocytes [Vogel et al., 1996]. Tissue proximal to the
progress zone, being no longer influenced by the AER, becomes influenced by bone morphogenetic




This is expressed in the dorsal half of the limb and restricts the AER to the distal tip of the developing limb,
by causing expression of Serrate-2, which defines the border of the AER [Laufer et al., 1997]. Engrailed-1
suppresses the expression of R-fng and therefore Serrate-2 and influence the formation of the AER
Hox-A and
Hox-D clusters
These control patterning and hence morphology of the developing limb in the human embryo. The
Meis1/2, Hoxa11, and Hoxa13 expression domains mark the three proximo-distal territories
(stylopod—Meis1/2, zeugopod—Hoxa11, and autopod—Hoxa13) [Be´nazet and Zeller, 2009]. In the
stylopod stage,Hoxd-9 andHoxd-10 express during the formation of the humerus. In the zeugopod stage,
Hoxd-9, Hoxd-10, Hoxd-11, Hoxd-12, and Hoxd-13 overlap in their expression to form the radius/tibia
and the ulna/fibula. In the autopod stage,Hoxa-12,Hoxa-13,Hoxd-10,Hoxd-11,Hoxd-12, andHoxd-13
express to form the developing hand and foot
Hoxb-8 Hoxb-8 and retinoic acid act on the posterior mesoderm to initiate the ZPA in the posterior border of the
limb, close to the AER and adjacent to the body wall [Charite et al., 1994; Scadding, 1999]
SHH (Sonic
Hedge hog)
This controls the development of the antero-posterior axis [Riddle et al., 1993]. Shh stimulates Fgfs in the
AER, and Fgfs in AER activate Shh in the ZPA, to develop more than one axis
Wnt7a This maintains the Shh signal once it has been initiated. The regulated expression or suppression ofWnt7a
controls patterning in the dorso-ventral axis. It also influences anterior–posterior patterning by
promoting Shh expression in the ZPA [Tickle, 2003]. Mutation ofWNT7A has been found related with




They induce the formation of bone and cartilage. BMP2, BMP4, and BMP7 are found in the developing
mesoderm and the AER, and have important roles in skeletal development. BMPs are expressed in
response to the Shh signal pathway. BMP2 plays a key role in osteoblast differentiation and induction of
bone formation. BMP4 regulates the formation of limbs from the mesoderm, and BMP7 is important in
osteoblast differentiation. BMP2 and BMP7, under the influence of Shh play a crucial role in digit
identity and formation [Barham and Clarke, 2008]
Sox9 This initiates the condensation and differentiation of chondroblasts in the embryonic limb. Cartilage fails
to develop in limbs where Sox9 is inactivated [Foster, 1996; Akiyama et al., 2002]
Cbfa1 This transcription factor regulates chondrocyte maturation and osteoblast differentiation
AER, apical ectodermal ridge; ZPA, zone of polarizing activity.
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amelia cases were SB, this figure being
much higher than in the study of
Martı´nez-Frı´as et al. [1997a] (16.7%,
n¼ 18).
Amelia affected the upper and lower
limbs equally in the study of Froster-
Iskenius and Baird [1990], and 11.1%
(n¼ 18) of liveborn cases had both
the upper and lower limbs affected.
However, in the study of Martı´nez-Frı´as
et al. [1997a], globally, the lower limbs
were affected in 72.2% of cases (n¼ 18).
Regarding laterality, according to
data of Froster-Iskenius and Baird [1990]
(n¼ 18), bilateral amelia occurred in
22% of cases, left-sided defects occurred
in 50%, and right-sided defects occurred
in 28%; this difference between left- and
right-sided defects was not statistically
significant. In the study of Martı´nez-
Frı´as et al. [1997a], 16.7% (n¼ 18) of
cases were bilateral, 33.3% had the left
side involved and 50% the right one;
most cases (83.3%) had absence of one
limb, and three (16.7%) had absence of
two limbs. Amelia involved a single limb
in 58% (n¼ 24) of cases with anomalies
in other organ systems in addition
to amelia in the study of Evans et al.
[1994].
The sex ratio in the studyof Froster-
Iskenius and Baird [1990] (11 males to
7 females) was not significantly different
from the one among LB in the general
population of British Columbia during
the study period. However, according to
the data of Martı´nez-Frı´as et al. [1997a],
there was a small excess of females
affected (7 males to 9 females), although
this ratio was not significantly different
from that found by Froster-Iskenius and
Baird [1990] or from that of the general
population in Spain (1.06 males to
1 female) [Martı´nez-Frı´as et al., 1997a].
According to data derived from the
TABLE II. Syndromes or Defined Phenotypes Presenting With Amelia [Winter and Baraitser, 2010; OMIM, 2011]
Syndrome or defined phenotype OMIM number, or Refs. Location
Human
gene/locus
Amelia, anorectal, and genital atresia Ghosh and Gupta [2004] — —
CHILD (congenital hemidysplasia, ichthyosis, limb defects) 308050 Xq28 NSDHL
Cloacal extrophy and limb defects Sawaya et al. [2010] — —
Diaphragmatic hernia limb anomalies Lai et al. [2010] — —
Disorganization-like 223200 — —
DK-phocomelia 223340 — —
Femur-fibula-ulna (FFU) complex 228200 — —
Fetal alcohol syndrome Pauli and Feldman [1986] — —
Fetal bifonazole Linder et al. [2010] — —
Fetal cocaine Marles et al. [2003] — —
Fetal thalidomide Lenz [1961, 1962], McCredie
and Willert [1999]
— —
Fibular aplasia, oligodactyly, camptomelia 246570 — —
Glass—ear anomalies, clefting, limb reduction defects Glass et al. [1994] — —
LL syndrome—amelia, upper limb defects Lazjuk et al. [1976] — —
Maternal diabetes syndrome Martı´nez-Frı´as [1994] — —
McKusick—cataract, unilateral limb defects 246000 — —
Michaud—autosomal recessive amelia 601360 — —
Microgastria—upper limb anomalies 156810 — —
Ohdo—tetraamelia, facial abnormalities, mental retardation 273390 — —
Popliteal pterygium syndrome 119500 1q32.3-q41 IRF6
Ratan—limb defects, imperforate anus, ventricular septal defect Ratan et al. [2005] — —
Roberts (pseudothalidomide) syndrome 268300 8p21.1 ESCO2
Schinzel—phocomelia and additional anomalies 276820 3p25 WNT7A
Splenogonadal fusion-limb defects 183300 — —
Steinfeld—holoprosencephaly, limb defects 184705 — —
Upper limb amelia, male pseudohermaphroditism Ohro et al. [1998] — —
Urioste—limb deficiency, vertebral hypersegmentation,
absent thymus
Urioste et al. [1996],
Martı´nez-Frı´as et al. [1997b]
— —
VACTERL (vertebral, anal, cardiac, tracheo-esophageal,
renal and limb defects)
192350 2q31.1 HOXD13
XK-aprosencephaly 207770 — —
Yim—amelia, hydrocephalus, iris coloboma, cleft lip/palate Kariminejad et al. [2009] — —
292 AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) ARTICLE
World Health Organization (WHO)
database, the proportion of male
newborns, although subject to geo-
graphical variation, is approximately
51% [Parazzini et al., 1998]. Neverthe-
less, the small excess of females in
the study of Martı´nez-Frı´as et al.
[1997a] could be due just to small
numbers.
Regarding other characteristics of
infants with amelia, some were studied
by Martı´nez-Frı´as et al. [1997a]. The
birth weight and gestational age of
amelia cases were significantly lower
than among the healthy controls. The
mean birth weight of amelia cases was
below the 3rd centile for the mean
gestational age (35.47 weeks), which
could be expected due to the absence
of the limb(s). Breech and other non-
cephalic presentations at birth were
more frequent among cases (46.7%,
n¼ 18) than among controls (3.9%,
n¼ 25,086). The percentage of a single
umbilical artery was also significantly
higher (57.1%, n¼ 7) than among con-
trols (1.1%, n¼ 14,482).
None of the cases included in the
study of Froster-Iskenius and Baird
[1990] (n¼ 18) had a family member
registeredwith a limb anomaly, although
the brother of a stillborn index patient
had imperforate anus, and a cousin had
meningomyelocele with hydrocephaly,
which the authors interpreted as a
possible familial recurrence of an
early disturbance of development.
There were three further cases with
apparently unrelated defects among their
relatives.
Associated Defects
In the study of Froster-Iskenius and
Baird [1990], up to 61% of the LB
(n¼ 18) and 100% of the SB amelia cases
(n¼ 6) also had associated defects. The
prevalence with which malformations
in other organ systems were present in
liveborn individuals with amelia was not
different from that in cases with all types
of limb reduction defects (348 out of
659). The most frequently occurring
additional malformation among amelia
cases was omphalocele (six LB and three
SB), which occurred together with
neural tube defects in two cases, and
with absent diaphragm but no neural
tube defect in three cases. One LB case
and two SB had anencephaly. Similarly,
the kidney was absent unilaterally in
two LB and two SB. Cleft lip (with or
without cleft palate) also occurred in
two LB and two SB cases with amelia.
All these prevalences are much higher
than expected.
In the study of Evans et al. [1994],
56.3% (n¼ 16) of the cases had defects
in other organs, a percentage which
was slightly lower than in the study of
Froster-Iskenius and Baird [1990], and
much lower than in the one by Castilla
et al. [1995] (72%, n¼ 50). According to
data of Evans et al. [1994], there was a
high prevalence of body wall defects,
anencephaly, and cleft lip among the
amelia cases. These associations were
also reported by Froster-Iskenius and
Baird [1990] and Mastroiacovo et al.
[1992].
The study by Martı´nez-Frı´as et al.
[1997a] (n¼ 18) reported no cases with
omphalocele but noted renal anomalies
in 27.8% of cases, body wall defects also
in 27.8%, neural tube defects in 16.7%,
cleft lip (with or without cleft palate)
in 11.1%, and diaphragmatic defects in
11.1% of the cases.
Rosano et al. [2000] found that the
total prevalence of amelia combined
with other major congenital anomalies
was 0.77 per 100,000 births (0.08 among
LB, 0.62 among SB, and 0.08 among
elective terminations of pregnancy
for fetal anomalies (ETOPFA)).
Those authors found significant asso-
ciations with gastroschisis, unilateral
kidney dysgenesis, severe defects of
genitalia, ring constriction-amniotic
TABLE III. Prevalence of Amelia From Various Published Studies
Study Prevalence Population/sample
Referred to total births
Castilla et al. [1995] 1.71 per 100,000 births 2,917,074 births
Evans et al. [1994] 1.02 per 100,000 births 1,575,904 births
Ka¨lle´n et al. [1984] 0.95 per 100,000 births 1,368,024 births
Martı´nez-Frı´as et al. [1997a] 1.50 per 100,000 births 1,198,580 births
Mastroiacovo et al. [1992] 1.50 per 100,000 births 9,848,000 births
Referred to live births
Bod et al. [1983] 0.53 per 100,000 LB 561,915 LB
Froster-Iskenius and Baird [1990] 1.48 per 100,000 LB 1,213,913 LB
Martı´nez-Frı´as et al. [1997a] 1.12 per 100,000 LB 1,333,879 LB
Birch-Jensen [1949] 0.2a per 100,000 LB Nonspecified number of LB
Referred to stillbirths
Martı´nez-Frı´as et al. [1997a] 34.56 per 100,000 SB 8,680 SB
Froster and Baird [1993] 79.05 per 100,000 SB 7,590 SB
LB, live births; SB: stillbirths.
aIncludes only amelia of the upper limb.
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bands, omphalocele, and anorectal
atresia.
Risk Factors and Prevention
We failed to find additional published
studies that specifically focused on risk
factors for amelia. Since amelia has been
described in several infants exposed to
thalidomide, from studies on this drug, it
was concluded that the sensitive period
for producing amelia extends from days
24 to 29 after fertilization for the upper
limbs and days 27 to 31 for the lower
limbs [Brent and Holmes, 1988]. In the
study of Martı´nez-Frı´as et al. [1997a],
the proportion of infants with amelia
whose mothers had vaginal bleeding
during pregnancy (41.2%, n¼ 18) was
significantly higher than that among
control infants (11.1%, n¼ 25,048;
P¼ 0.001); parental ages did not sig-
nificantly differ from the ones observed
among controls.
There are limited published data on
the prevention of amelia. However,
there is some suggestion that maternal
periconceptional multivitamin use may
be associated with a lower risk for
transverse limb deficiencies [Yang et al.,
1997], and for limb defects in general
[Botto et al., 2004; Czeizel, 2004].
In order to expand on the limited
information on the epidemiology of
amelia, we conducted a descriptive
analysis of prevalence data collected
on this congenital defect reported by
surveillance programs of the Interna-
tional Clearinghouse for Birth Defects
Surveillance and Research (ICBDSR).
In this analysis, we examined the varia-
tion in total prevalence by program
and by selected maternal and infant
characteristics.
METHODS
Data were derived from the 20 surveil-
lance programs for congenital anomalies
listed in Table IV, all of which are
members of the ICBDSR [2011a,b].
The data represented 23 countries and
4 continents (all but Africa). Two
countries have three or more programs,
and one (ECLAMC-Estudio Colabor-
ativo Latino-Americano de Malforma-
ciones Conge´nitas) includes data from
10 different South American countries.
A total of 23,110,591 births, including
LB, SB and, for some programs,
ETOPFA, were surveyed from 1968 to
2006, although the study period was
variable among programs. For each
TABLE IV. Total Prevalence of Amelia in 20 Surveillance Programs of the International Clearinghouse for Birth Defects
Surveillance and Research












Canada Alberta 1980–2005 1,062,483 17 23.5 41.2 1.60 0.93–2.56
USA Utah 1997–2004 380,706 2 50.0 0 0.53 0.06–1.90
USA Atlanta 1968–2004 1,283,999 20 25.0 31.6 1.56 0.95–2.41
USA Texas 1996–2002 2,054,788 30 16.7 13.3 1.46 0.99–2.08
Mexico RYVEMCE 1978–2005 1,058,885 25 44.0 NP 2.36 1.53–3.49
South America ECLAMC 1982–2006 4,556,173 52 34.6 NP 1.14 0.85–1.50
Finland 1993–2004 713,494 9 0 44.4 1.26 0.58–2.39
Northern Netherlands 1981–2003 369,658 3 0 0 0.81 0.17–2.37
Germany Saxony–Anhalt 1980–2004 355,184 2 50.0 50.0 0.56 0.07–2.03
Slovak Republic 2000–2005 318,257 6 16.7 0 1.89 0.69–4.10
France Central East 1979–2004 2,500,214 46 2.2 63.0 1.84 1.35–2.45
Italy North East 1981–2004 1,186,497 5 0 20.0 0.42 0.14–0.98
Italy Emilia Romagna 1982–2004 558,176 9 0 22.2 1.61 0.74–3.06
Italy Tuscany 1992–2004 336,744 4 0 0 1.19 0.32–3.04
Italy Campania 1992–2004 643,962 3 0 33.3 0.47 0.10–1.36
Italy Sicily 1991–2002 216,257 4 0 25.0 1.85 0.50–4.74
Spain ECEMC 1980–2004 2,045,751 15 13.3 NR 0.73 0.41–1.21
Israel 1975–2005 151,562 3 0 33.3 1.98 0.41–5.78
China Beijing 1992–2005 1,927,622 47 44.7 NR 2.44 1.79–3.24
Australia Victoria 1983–2004 1,390,179 24 58.3 25.0 1.73 1.11–2.57
Total 23,110,591 326 25.8 19.0a 1.41 1.26–1.57
ECEMC, Estudio Colaborativo Espan˜ol de Malformaciones Conge´nitas; ECLAMC, Estudio Colaborativo Latino-Americano de
MalformacionesConge´nitas;RYVEMCE,RegistroyVigilancia Epidemiolo´gica deMalformacionesConge´nitas; SB, stillbirths; ETOPFA,
elective termination of pregnancy for fetal anomaly; CI, confidence interval; NP, not permitted; NR, not reported.
aThe percentage computed on the 16 programs registering ETOPFA is 33.2% (n¼ 62/187).
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population, the number of births and the
maternal age distributionwere reported.
Programs were asked to provide de-
identified information on the cases,
following a common protocol, includ-
ing data on phenotype, results of any
genetic testing, and selected demo-
graphic and prenatal information, as it
is explained in detail in the article by
Castilla and Mastroiacovo [in press] in
this issue of the journal. Local scrutinyof
the cases was performed by the most
qualified dysmorphologist involved in
each surveillance program, using all the
available documentation. This means
that he/she tried to confirm that the
proximal humerus or femur were absent
in cases with clinical amelia. Addition-
ally, the collected data for this studywere
furthermore reviewed by three of the
authors (E.B-S., M-L.M-F., and P.M.),
who corresponded with the participat-
ing program directors when needed to
identify those cases strictly meeting the
case definition of amelia (complete absence of
one or more limbs) to be included in this
study. The study protocol underlined
that only cases with complete absence
should be included. Figure 1 illustrates
several amelia cases, showing total
absence of a limb. Amputations in the
context of amniotic bands or limb-body
wall complex (LBWC) were not
included. In fact, there may be an
etiologic distinction between amelia
combined with gross body wall defects
and amelia in cases with no gross body
wall defect [Mastroiacovo et al., 1992].
The total prevalence of amelia was
estimated for each program (LBþ SBþ
ETOPFA cases divided by all LBþ SB)
with 95% confidence intervals (CI)
calculated using the Poisson distribu-
tion. More details on the statistical
methodology used in this project are
provided by Castilla and Mastroiacovo
[in press] in this issue.
Cases included in the analyses
were classified as: (1) isolated if amelia
was the only defect present, and (2)
multiple congenital anomalies (MCA)
if unrelated defects were present in
addition to amelia. Therewere 101 cases
with isolated amelia and 218 with
amelia in MCA. The remaining seven
cases had known syndromes and
were excluded from these analyses
since their cause is already known or
suspected.
Distributions for categorical varia-
bles were compared with w2 tests or
Fisher’s exact tests. Prevalence ratios
with corresponding 95% CI were calcu-
lated for 5-year maternal age groups
relative to the reference age group of
mothers younger than 20 years. The risk
of developing amelia with associated
malformations compared with isolated
amelia cases in relation to different
variables was examined with odds ratios
(ORs) and their 95% CI; the adjusted
ORs (aORs) were obtained after adjust-
ment for tertiles of percentage of MCA
cases (a new variable was created from
the percentage of MCA cases in each
program, so that each program was
assigned a value for this variable depend-
ing on the corresponding tertile, and the
adjustment was made for that new
variable). We conducted the logistic
regression analyses of variables using
Stata (Statistics/Data Analysis) Special
Edition 8.0. P-values lower than 0.05
were considered statistically significant.
Additional information on the method-
ology, variables, data gathered and
analyses for this study are detailed in
the article by Castilla and Mastroiacovo
[in press].
RESULTS
A total of 326 cases with amelia were
detected among a total of 23,110,591
Figure 1. Clinical photographs of some amelia cases, showing total absence of a
limb; (a) amelia of the upper left limb; (b) amelia of the right lower limb; (c) amelia of the
right upper limb combinedwith anencephaly; (d-1,d-2, and d-3) amelia of a lower limb
combined with phocomelia of the contralateral lower limb (Courtesy of Dr. A. Sanchis,
Dr. S. Martı´nez, Dr. I. Arroyo Carrera, and Dr. E. Buro´n).
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births (LB, SB and, for some programs,
ETOPFA), for an overall total preva-
lence of 1.41 per 100,000 (95% CI:
1.26–1.57). This estimates that there
was at least one case with amelia in every
63,694–79,365 births. Among the total
A total of 326 cases with amelia
were detected among a total of
23,110,591 births (LB, SB and,
for some programs, ETOPFA),
for an overall total prevalence
of 1.41 per 100,000 (95% CI:
1.26–1.57). This estimates
that there was at least one
case with amelia in every
63,694–79,365 births.
amelia cases, 54.6% were LB infants,
25.8% were SB, and 19.0% were
ETOPFA. In 0.6% the pregnancy out-
come was not specified.
Table IV shows the participating
surveillance programs and specifies the
study period, number of births surveyed,
number of amelia cases, percentage of
SB, percentage of ETOPFA, total prev-
alence, and 95% CI. Four programs
contributed approximately 50% of the
cases (South America ECLAMC, China
Beijing, France Central East, and
USA Texas). Figure 2 presents the total
prevalence and 95% CI for each pro-
gram, compared with the overall total
prevalence. Total prevalence for individ-
ual programs differed significantly from
the overall total estimate for a lower
estimate in Italy North East (0.42 per
100,000; CI: 0.14–0.98; P¼ 0.0008),
Italy Campania (0.47 per 100,000;
CI: 0.10–1.36; P¼ 0.02), and Spain
ECEMC (Spanish Collaborative Study
of CongenitalMalformations) (0.73; CI:
0.41–1.21; P¼ 0.035), and a higher
estimate in China Beijing (2.44; CI:
1.79–3.24; P¼ 0.0004) and Mexico
RYVEMCE (Registro y Vigilancia
Epidemiolo´gica de Malformaciones
Conge´nitas) (2.36; CI: 1.53–3.49;
P¼ 0.011).
Regarding the distribution of
the cases by clinical presentation,
101 (31.0%) had isolated amelia and
218 (66.9%) had MCA. Seven (2.1%)
had different syndromes: one case
with Brachmann-de Lange syndrome
(OMIM: 122470) [OMIM, 2011],
two with Roberts syndrome (OMIM:
268300), one with FFU (femur-fibula-
ulna) syndrome (OMIM: 228200),
one with trisomy 13, and two with the
particular phenotype combining severe
limb defects, vertebral hypersegmenta-
tion and mirror polydactyly, with sug-
gested autosomal recessive inheritance
[Urioste et al., 1996; Martı´nez-Frı´as
et al., 1997b].
Among the nonsyndromic cases
65.2% were monomelic, with absence
of only one limb, and 32.6% were
dimelic (Table V). Only one case had
absence of three limbs, and four cases
(1.7% of the total) had absence of all four
limbs. Among those monomelic cases,
each side was affected with equal
frequency, with the upper limbs affected
slightly more frequently than the lower
(53.9%vs. 46.1%). Among dimelic cases,
the upper limbswere affectedmore often
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Figure 2. Total prevalence of amelia per 100,000 births (bar) and 95% confidence
interval (bracketed line) by surveillance program, and overall total prevalence (dotted
line), in 20 surveillance programs of the International Clearinghouse for Birth Defects
Surveillance and Research.
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Table VI depicts some character-
istics of the 319 nonsyndromic cases
with amelia (101 isolated and 218 with
MCA). Overall, cases were more often
male (52.4%) than female (34.5%) with
8.8% having indeterminate sex and 4.4%
with sex not stated. Among the isolated
cases, the male to female ratio (1.74,
61 males to 35 females) was slightly
higher (no statistical difference) than
among caseswithMCA (1.41, 106males
to 75 females). With respect to birth
outcomes, most cases (53.9%) were LB,
reaching 61.4% and 50.5% among
isolated and MCA cases, respectively.
Regarding birth weight of nonsyn-
dromic liveborn cases, a high proportion
of them (40.7%) weighed 2,500 g or
more; cases with MCAwere more likely
to weigh between 1,500 and 2,499 g or
less than 1,500 g, than thosewith isolated
amelia. Most amelia cases (56.4%) were
born at term, but cases with MCAwere
more likely to be born before 32 weeks
(31.8% vs. 6.5% among isolated). Multi-
ple deliveries accounted for 7.8% of
nonsyndromic cases. The distribution by
maternal age showed that the most
numerous maternal age group was that
of mothers aged 20–24 years (31.3% of
all cases). A high percentage of missing
data for previous parity, previous spon-
taneous abortions, parental age differ-
ence, and years of maternal education
made these variables difficult to study.
Figure 3 shows the prevalence ratios
and corresponding 95%CIs for maternal
age groups relative to the reference
age group of mothers younger than
20 years. There was a statistically signifi-
cant decreasing trend (P¼ 0.0026) in the
prevalencewith advancingmaternal age,
with the three maternal age groups of
25–29, 30–34, and 35–39 years having
statistically significant lower prevalences
of amelia compared with the reference
group.
Table VII summarizes the compari-
son of possible factors or variables
associated with MCA versus isolated
cases using only data from surveillance
programs with less than 20% of missing
data values. The analyses were adjusted
for tertiles of percentage of MCA cases
observed in each program. Among
MCA cases, there were statistically
significantly higher risks for SB
(aOR¼ 5.18; 95% CI: 1.70–15.73)
and ETOPFA (aOR¼ 3.09; 95% CI:
1.41–6.79), and for premature birth
(gestational age <32 weeks: aOR¼
5.40, 95% CI: 1.61–18.08; gestational
age 32–36weeks: aOR¼ 3.17, 95%CI:
1.13–8.92). There were no statistically
significant differences for previous parity
and previous spontaneous abortions.
Twins were associated with MCA
(aOR¼ 2.95), although this result was
almostmarginally statistically significant.
Regarding the comparison of maternal
age groups and parental age difference,
no statistically significant result was
found (Table VII).
Table VIII lists the specific defects
associated with amelia (excluding other
limb reduction defects), and their fre-
quencies by three-digit International
Classification of Diseases, Tenth Revi-
sion (ICD-10) code among cases with
MCA (n¼ 218). Defects present in
more than 10% of amelia cases were:
musculoskeletal congenital malforma-
tions not elsewhere classified (39.9%);
congenital malformations of the spine
and bony thorax (22.5%); congenital
malformations involving the limbs (ex-
cluding limb reduction defects) (21.1%);
absence, atresia, or stenosis of the large
intestine (18.8%); renal agenesis and
other reduction of kidney (16.5%);
indeterminate sex and pseudohermaph-
roditism (14.7%); musculoskeletal de-
formities of the head, face, spine, and
chest (13.8%); congenital deformity of
the feet (13.8%); cleft palatewith cleft lip
(11.0%); congenital malformations of
the cardiac septa (11.0%); and anen-
cephaly (10.1%). For other defects that
have been associated with amelia in the
literature, we found the following per-
centages (data not shown in Table VIII):
gastroschisis was observed in 11.9% of
our MCA cases, omphalocele in 9.2%,
diaphragmatic defects in 3.2%, and
anorectal atresia or stenosis in 16.1% of
MCA cases in our series.
DISCUSSION
This report is based on the largest series
of amelia cases known to date. Among
more than 23.1 million births from all
over the world, the overall total preva-
lence of amelia was 1.41 per 100,000,
and ranged from a minimum of 0.42 to
a maximum of 2.44. This overall
total prevalence falls within the range
described by other authors among total
TABLE V. Distribution of Nonsyndromica Amelia Cases by Number of
Affected Limbs, Upper/Lower Limb Involvement and Laterality of the Defect,
Among 20 Surveillance Programs of the International Clearinghouse for Birth
Defects Surveillance and Research
N % % of Total cases
Monomelic
Upper right 38 25.0
Upper left 44 28.9
Lower right 38 25.0
Lower left 32 21.1





Total dimelic 76 100 32.6
Trimelic 1 — 0.4
Tetramelic 4 — 1.7
Total (specified) 233 — 100
aSyndromic cases (n¼ 7) were excluded for this and the following analyses.
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TABLE VI. Characteristics of Nonsyndromica Cases With Amelia and by Clinical Phenotype Among 20 Surveillance




Cases with isolated amelia
(n¼ 101)
Cases with amelia and MCA
(n¼ 218)
n (%) n (%) n (%)
Sex
Male 167 52.4 61 60.4 106 48.6
Female 110 34.5 35 34.7 75 34.4
Indeterminate 28 8.8 0 0.0 28 12.8
Missing data 14 4.4 5 5.0 9 4.1
Outcome
Live births 172 53.9 62 61.4 110 50.5
Stillbirths 84 26.3 23 22.8 61 28.0
ETOPFA 62 19.4 16 15.8 46 21.1
Missing data 1 0.3 0 0.0 1 0.5
Birth weight among live births (g)
<1,500 26 15.1 6 9.7 20 18.2
1,500–2,499 58 33.7 18 29.0 40 36.4
2,500 70 40.7 36 58.1 34 30.9
Missing data 18 10.5 2 3.2 16 14.5
Gestational age among live births (weeks)
< 32 39 22.7 4 6.5 35 31.8
33–36 29 16.9 8 12.9 21 19.1
37 97 56.4 46 74.2 51 46.4
Missing data 7 4.1 4 6.5 3 2.7
Previous parity
0 71 22.3 32 31.7 39 17.9
1 102 32.0 25 24.8 77 35.3
2 49 15.4 19 18.8 30 13.8
Missing data 97 30.4 25 24.8 72 33.0
Previous spontaneous abortions
0 124 38.9 44 43.6 80 36.7
1 27 8.5 11 10.9 16 7.3
Missing data 168 52.7 46 45.5 122 56.0
Plurality
Single 278 87.1 93 92.1 185 84.9
Twin 24 7.5 4 4.0 20 9.2
Triplet 1 0.3 0 0.0 1 0.5
Missing data 16 5.0 4 4.0 12 5.5
Maternal age
<20 38 11.9 11 10.9 27 12.4
20–24 100 31.3 31 30.7 69 31.7
25–29 81 25.4 26 25.7 55 25.2
30–34 60 18.8 25 24.8 35 16.1
35 22 6.9 4 4.0 18 8.3
Missing data 18 5.6 4 4.0 14 6.4
Parental age difference
Mother same age or older 32 10.0 14 13.9 18 8.3
Mother 1–2 years younger 26 8.2 11 10.9 15 6.9
Mother 3–4 years younger 30 9.4 14 13.9 16 7.3
Mother >4 years younger 26 8.2 6 5.9 20 9.2
Missing data 205 64.3 56 55.4 149 68.3
Maternal education (years)
<9 27 8.5 10 9.9 17 7.8
9 70 21.9 20 19.8 50 22.9
Missing data 222 69.6 71 70.3 151 69.3
aSyndromic cases (n¼ 7) were excluded from analysis.
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births of 0.95 per 100,000 [Ka¨lle´n et al.,
1984] to 1.71 per 100,000 [Castilla et al.,
1995] (Table III). However, some of the
cases included in these two reports were
also included in our study. The high total
prevalences observed in China Beijing
and Mexico RYVEMCE in our study
(although marginally significant in this
last program) are even higher than that
of Castilla et al. [1995]. The apparently
low total prevalence reported by Spain
ECEMC (also marginally significant) is
probably due to the lack of inclusion of
ETOPFA in the prevalence estimate,
since prior to passage in 1985 of a law
permitting ETOPFA in Spain the total
birth prevalence was even higher (1.83
per 100,000; CI: 0.74–3.77) than the
overall total prevalence in our study
(although not significantly different).
Another factor contributing to the low-
est end of the prevalence in our study
could be under-registration (e.g., Italy
North East and Italy Campania—for this
last registry only a marginally statistically
significant result was obtained for its low
total prevalence). However, since amelia
is a very obvious defect, it is unlikely that
it goes unnoticed. Therefore, under-
ascertainment does not seem a plausible
explanation and we consider that a more
likely contributor to the variation in
total prevalence among programs might
be differences in classification of amelia
cases under other less specific categories
of limb defects, such as transverse limb
deficiencies. This issue highlights one
of the primary problems regarding limb
defects: their classification. In many
studies in the literature, limb defects are
analyzed together as a single group;
however, in other studies, different
classification systems have been used
preventing the comparison of results.
In several instances, amelia has been
analyzed jointly with phocomelia
[Ka¨lle´n et al., 1984], with other trans-
verse limb defects [Calzolari et al., 1990;
Lin et al., 1993], or with limb reduction
defects considered as a whole in many
studies. This lack of standardization or
harmonization could reflect the lack
of a completely satisfactory classification
for limb deficiencies, one that complies
with both developmental and causal
boundaries, as stated by Botto et al.
[1998]. Other factors that could con-
tribute to under-registration of amelia
cases may be linked to the methods and
organization of the surveillance pro-
grams, especially if birth defects reported
on notification forms are the main or
only source of case identification.
It is important to underline the need
for a proper examination of cases, in
order to confirm the absence of the
proximal segment of the humerus or
femur before considering that a case has
amelia. For these purposes, a radiologi-
cal examination is essential to exclude
the presence of any bony structure in the
limb.Moreover, taking into account that
many of the pregnancies in which the
fetus presents with amelia are subject to
ETOPFA, a complete study of those
fetuses is essential to adequately charac-
terize not only amelia, but all the defects
to which it is associated (what is also
critical to provide a proper counseling to
the parents regarding recurrence risks
and early detection possibilities in future
pregnancies). This could be a limitation
of this study, because although the study
protocol included a very clear and strict
definition of amelia, if in some cases
the radiological study was not available
for review, or if in cases of ETOPFA
the fetus could not be completely
studied, some misclassification cannot
be completely excluded.
Regarding the outcome, we ob-
served that 25.8% of amelia cases were
SB, this estimate being higher than that
reported byMartı´nez-Frı´as et al. [1997a]
(16.7%, n¼ 18), and lower than that
reported in the study of Castilla et al.
[1995] (34%, n¼ 50). Our percentage of
cases with other defects associated with
amelia (69% when including the seven
cases with different syndromes) is higher
than that reported by Froster-Iskenius
and Baird [1990] among liveborn cases
(61%, n¼ 18), and Evans et al. [1994]
Figure 3. Prevalence ratios for maternal age groups relative to the reference age of
<20 years with corresponding 95% CIs for amelia in 18 surveillance programs* of the
International Clearinghouse for Birth Defects Surveillance and Research (syndromic
cases excluded). *Cases and births excluded for the following programs because no births
by maternal age were available: China Beijing <1997 and >2003, Germany Saxony–
Anhalt <1991, Italy Emilia Romagna <1985, Italy North East, Italy Sicily.
In many studies in the
literature, limb defects are
analyzed together as a single
group; however, in other
studies, different classification
systems have been used
preventing the comparison of
results. In several instances,
amelia has been analyzed
jointly with phocomelia, with
other transverse limb defects,
or with limb reduction defects
considered as a whole
in many studies.
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(56.3%, n¼ 16), but slightly lower than
the 72% (n¼ 50) described by Castilla
et al. [1995] (72%, n¼ 50).
The small number of syndromes
detected among amelia cases in our study
is striking. This finding is consistent
with the low frequency of syndromes
associated with amelia in the literature
(Table II); the hypothesis that amelia
has fewer etiologies compared with the
broader categories of limb reduction
defects [Brent and Holmes, 1988]; and
the fact that amelia is not generally
considered to be of genetic origin [Lenz,
1980]. Two of the amelia cases included
in our study had already being described
in two other reports of a possibly new
syndrome characterized by the presence
TABLE VII. Crude and Adjusted Odds Ratios (OR) With 95% Confidence Intervals (95% CI) for the Association of
Various Characteristics Among Multiple Congenital Anomalies Cases (Cases) Versus Isolated Cases (Controls) of Amelia
Reported by 20 Surveillance Programs of the International Clearinghouse for Birth Defects Surveillance and Research




Male 1.00 Referent 1.00 Referent
Female 1.23 0.74 2.05 1.21 0.71 2.05
Outcome
Live births 1.00 Referent 1.00 Referent
Stillbirths 4.81 1.70 13.66 5.18 1.70 15.73
ETOPFA 2.56 1.26 5.20 3.09 1.41 6.79
Birth weight among live births (g)
<1,500 3.53 1.26 9.84 2.63 0.81 8.47
1,500–2,499 2.35 1.14 4.87 1.64 0.74 3.65
2,500 1.00 Referent 1.00 Referent
Gestational age among live births (weeks)
<32 7.89 2.60 23.91 5.40 1.61 18.08
32–36 2.37 0.96 5.86 3.17 1.13 8.92
37 1.00 Referent 1.00 Referent
Previous parity
0 1.00 Referent 1.00 Referent
1 2.85 1.39 5.83 1.60 0.68 3.73
2 1.49 0.64 3.45 1.06 0.40 2.80
Previous spontaneous abortions
0 1.00 Referent 1.00 Referent
1 0.69 0.29 1.66 0.64 0.25 1.69
Plurality
Single 1.00 Referent 1.00 Referent
Twin 2.51 0.83 7.57 2.95 0.92 9.45
Maternal age
<20 1.00 Referent 1.00 Referent
20–24 0.91 0.40 2.06 1.24 0.53 2.90
25–29 0.86 0.37 2.00 1.38 0.56 3.38
30–34 0.57 0.24 1.36 0.91 0.36 2.28
35 1.83 0.50 6.66 2.89 0.74 11.21
Parental age difference
Mother same age or older 0.94 0.33 2.68 0.83 0.26 2.64
Mother 1–2 years younger 1.00 Referent 1.00 Referent
Mother 3–4 years younger 0.84 0.29 2.41 0.58 0.18 1.90
Mother >4 years younger 2.44 0.74 8.11 2.91 0.75 11.29
ETOPFA, elective termination of pregnancy for fetal anomalies; aOR, adjusted odds ratio.
OR computed only for the 16 programs reporting ETOPFA; surveillance programs with more than 20%missing data were excluded from
the analysis; seven cases with syndromes were excluded from the analysis.
aAdjustments were made for tertiles of percentage of MCA cases in each program.
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TABLE VIII. Associated Defects Among Nonsyndromic Amelia Cases, Excluding Other Limb Reduction Defects,
Reported by 20 Surveillance Programs of the International Clearinghouse for Birth Defects Surveillance and Research
Associated defects ICD-10 Code (3 digits) N %
Anencephaly Q00 22 10.1
Encephalocele Q01 13 6.0
Microcephaly Q02 2 0.9
Hydrocephalus Q03 18 8.3
Other CM of brain Q04 14 6.4
Spina bifida Q05 9 4.1
Other CM of spinal cord Q06 2 0.9
CM of eyelid, lacrimal system and orbit Q10 2 0.9
Anophthalmos/microphtalmos and macrophthalmos Q11 15 6.9
CM of the lens Q12 1 0.5
CM of posterior segment of eye Q14 1 0.5
Other CM of eye Q15 8 3.7
CM of ear causing impairment of hearing Q16 6 2.8
Other CM of ear Q17 20 9.2
CM of face and neck Q18 18 8.3
CM of cardiac chambers and connections Q20 6 2.8
CM of cardiac septa Q21 24 11.0
CM of pulmonary and tricuspid valves Q22 5 2.3
CM of aortic and mitral valves Q23 3 1.4
Other CM of heart Q24 14 6.4
CM of great arteries Q25 7 3.2
CM of great veins Q26 1 0.5
Other CM of peripheral vascular system Q27 15 6.9
Other CM of circulatory system Q28 1 0.5
CM of nose Q30 8 3.7
CM of lung Q33 17 7.8
Other CM of respiratory system Q34 7 3.2
Cleft palate Q35 6 2.8
Cleft lip Q36 6 2.8
Cleft palate with cleft lip Q37 24 11.0
Other CM of tongue, mouth and pharynx Q38 6 2.8
CM of esophagus Q39 8 3.7
Absence, atresia, and stenosis of small intestine Q41 4 1.8
Absence, atresia, and stenosis of large intestine Q42 41 18.8
Other CM of intestine Q43 13 6.0
CM of gallbladder, bile ducts, and liver Q44 4 1.8
Other CM of digestive system Q45 2 0.9
CM of ovaries, fallopian tubes and broad ligament Q50 12 5.5
CM of uterus and cervix Q51 8 3.7
Other CM of female genitalia Q52 9 4.1
Undescended and ectopic testicle Q53 7 3.2
Hypospadias Q54 4 1.8
Other CM of male genital organs Q55 11 5.0
Indeterminate sex and pseudohermaphroditism Q56 32 14.7
Renal agenesis and other reduction of kidney Q60 36 16.5
Cystic kidney Q61 7 3.2
Obstructive defects of renal pelvis and ureter Q62 17 7.8
Other CM of kidney Q63 8 3.7
Other CM of urinary system Q64 11 5.0
Congenital deformity of hips Q65 3 1.4
(Continued)
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of severe limb defects (including amelia),
vertebral hypersegmentation and mirror
polydactyly, and with suggested autoso-
mal recessive inheritance [Urioste et al.,
1996; Martı´nez-Frı´as et al., 1997b].
Each of these reports included two cases
each, and there have not been any
further reports of similar cases in the
literature.
Regarding the limbs affected,
65.2% of cases in our study were
monomelic, similar to the 58% (n¼ 24)
observed in the study of Evans et al.
[1994] among cases with other associat-
ed defects, and lower than the 83.3%
(n¼ 18) observed by Martı´nez-Frı´as
et al. [1997a]. Among our monomelic
cases, both sides were equally involved,
in contrast to the results of Froster-
Iskenius and Baird [1990], who found
more left-sided defects, and Martı´nez-
Frı´as et al. [1997a], who found more
right-sided defects. In our study, the
upper limbs were more frequently
affected (53.9% of monomelic cases); in
contrast, Froster-Iskenius and Baird
[1990] found that amelia affected equally
the upper and lower limbs, and Martı´-
nez-Frı´as et al. [1997a] reported a higher
frequency among the lower limbs
(72.2%). From our larger series, it seems
likely that there is no clear tendency of
either side to be more frequently affect-
ed, although the upper limbs seem to be
more frequently involved. This tenden-
cy appears more marked among dimelic
cases.
Overall, cases in our study were
more often males, and this was more
marked among the isolated cases.
However, Martı´nez-Frı´as et al. [1997a]
found a nonsignificant excess of females
affected (seven males to nine females),
although it could be due to the smaller
numbers. Froster-Iskenius and Baird
[1990] reported a sex-ratio favoring
males (11 males to 7 females), which
did not differ from that among LB in
the general population from which the
cases were ascertained.
Regarding the tendency for amelia
to be associated with other congenital
anomalies, we found that more cases had
MCA than not, and this tendency was
more marked among SB and ETOPFA.
This was not unexpected, since amelia
originates during blastogenesis and blas-
togenetic defects tend to be associated
with other severe and multiorganic
defects. The fact that MCA are more
frequent among stillborn cases could
indicate that themost severe defectswith
which amelia may be associated, might
cause an early death. These deaths of the
more severely affected fetuses would
result in a group of surviving fetuses
capable of progressing to be born at
term, and this could also explain the low
percentage of cases with a birth weight
below 1,500g observed in our data.
One of themost interesting findings
in this series is the higher prevalence of
amelia among younger mothers. As for
other defects showing a similar associa-
tion with a younger maternal age (such
as gastroschisis), this finding might
indicate that lifestyle or environmental
influences could be contributing factors
to at least some amelia cases. Moreover,
TABLE VIII. (Continued)
Associated defects ICD-10 Code (3 digits) N %
Congenital deformity of feet Q66 30 13.8
Musculoskeletal deformities of head, face, spine, and chest Q67 30 13.8
Other musculoskeletal deformities Q68 9 4.1
Polydactyly Q69 6 2.8
Syndactyly Q70 14 6.4
Other CM of limb(s) Q74 46 21.1
Other CM of skull and face bones Q75 11 5.0
CM of spine and bony thorax Q76 49 22.5
Non elsewhere classified musculoskeletal CM Q79 87 39.9
Other CM of skin Q82 12 5.5
CM of breast Q83 3 1.4
Other CM of integument Q84 3 1.4
Other syndromes affecting multiple systems Q87 17 7.8
Other CM, not elsewhere classified Q89 18 8.3
Total 218 100.0
CM, congenital malformations.
One of the most interesting
findings in this series is the
higher prevalence of amelia
among younger mothers.
As for other defects showing a
similar association with a
younger maternal age (such as
gastroschisis), this finding
might indicate that lifestyle or
environmental factors could be
contributing factors to at least
some amelia cases.
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since this association has already been
found also in relation with gastroschisis,
it could be hypothesized that a vascular
disruption might be in the origin of
amelia, so our results could also provide a
clue on the pathogenesis of this congen-
ital defect. To this respect, taking this
into account and all the knowledge
on thalidomide’s action mechanism, it
could also be hypothesized that there
might be other drugs or other environ-
mental factors with some influence on
the vasculature or blood supply to the
fetus that should be investigated in
relation with amelia.
Finally, the relative lack of informa-
tion on risk factors and causes of amelia
highlighted by a thorough review of
the literature underscores the need for
good classification and coding systems
and more collaborative research on
modifiable risk factors and causes for
this rare but severe congenital defect.
In this sense, according to present
times, it could be helpful to indicate
that up to now there has not been
enough experience with chromosome
microarray testing (at least in published
reports), and this could open new
avenues in the research on the causes of
amelia. Therefore, although quite spec-
ulative at present, it would be worth-
while to explore whole genome
microarray tests in patients with amelia
in order to find genomic variants that
could be directly associated to it, or other
that combined with some enviromental
hazards could increase the risk for this
severe limb defect.
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